Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

45.13. Analysis.

45.13

Comparison 45 Adverse events within six months: etanercept + disease‐modifying anti‐rheumatic drug (DMARD) vs. etanercept, Outcome 13 Injection site reaction/injection site haemorrhage/general disorders and administration site conditions.